Han Cui

987 total citations
21 papers, 829 citations indexed

About

Han Cui is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Han Cui has authored 21 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Biomaterials. Recurrent topics in Han Cui's work include Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Han Cui is often cited by papers focused on Nanoparticle-Based Drug Delivery (9 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (5 papers). Han Cui collaborates with scholars based in China and United States. Han Cui's co-authors include Siyuan Zhou, Qibing Mei, Daozhou Liu, Miao Liu, Bang‐Le Zhang, Ying Cheng, Ying Cheng, Meng‐Lei Huan, Zenghui Teng and Tiehong Yang and has published in prestigious journals such as PLoS ONE, Scientific Reports and Nanoscale.

In The Last Decade

Han Cui

20 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Han Cui China	15	371	249	209	116	101	21	829
Daozhou Liu China	19	526 1.4×	276 1.1×	278 1.3×	129 1.1×	124 1.2×	27	1.1k
Ying Cheng China	19	514 1.4×	153 0.6×	184 0.9×	139 1.2×	76 0.8×	50	1.1k
Sui Li-hua China	12	357 1.0×	105 0.4×	251 1.2×	78 0.7×	75 0.7×	24	812
Ruoqiu Fu China	15	498 1.3×	270 1.1×	182 0.9×	142 1.2×	51 0.5×	26	1.2k
Yun Luo China	17	392 1.1×	235 0.9×	248 1.2×	125 1.1×	32 0.3×	44	1.1k
Donghui Zheng China	24	667 1.8×	169 0.7×	325 1.6×	131 1.1×	72 0.7×	62	1.5k
Zhiyan Du China	21	810 2.2×	246 1.0×	147 0.7×	122 1.1×	55 0.5×	39	1.4k
Hongyu Qiao China	13	292 0.8×	109 0.4×	201 1.0×	50 0.4×	26 0.3×	23	757
Xiaojun Tao China	23	588 1.6×	315 1.3×	214 1.0×	128 1.1×	42 0.4×	58	1.3k

Countries citing papers authored by Han Cui

Since Specialization

Citations

This map shows the geographic impact of Han Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Cui more than expected).

Fields of papers citing papers by Han Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Cui. The network helps show where Han Cui may publish in the future.

Co-authorship network of co-authors of Han Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Han Cui. A scholar is included among the top collaborators of Han Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Cui. Han Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cui, Han, et al.. (2025). Single-Cell RNA Sequencing Delineates the Atlas and Cell Interactions of the Testicular Cells in Chinese Soft-Shelled Turtle (Pelodiscus sinensis). Marine Biotechnology. 27(4). 101–101.

Li, Yue, et al.. (2024). Dietary Iron Overload Triggers Hepatic Metabolic Disorders and Inflammation in Laying Hen. Biological Trace Element Research. 203(1). 346–357. 3 indexed citations

Cheng, Ying, Daozhou Liu, Miao Liu, et al.. (2019). Mitochondria-targeted cyclosporin A delivery system to treat myocardial ischemia reperfusion injury of rats. Journal of Nanobiotechnology. 17(1). 18–18. 180 indexed citations

Liu, Daozhou, Ying Cheng, Han Cui, et al.. (2019). Osteoclasts and tumor cells dual targeting nanoparticle to treat bone metastases of lung cancer. Nanomedicine Nanotechnology Biology and Medicine. 21. 102054–102054. 24 indexed citations

Cheng, Ying, Daozhou Liu, Han Cui, et al.. (2019). Mitochondria-targeted antioxidant delivery for precise treatment of myocardial ischemia–reperfusion injury through a multistage continuous targeted strategy. Nanomedicine Nanotechnology Biology and Medicine. 16. 236–249. 63 indexed citations

Huan, Meng‐Lei, Ying Cheng, Han Cui, et al.. (2019). Mitochondria and Nucleus Delivery of Active Form of 10-Hydroxycamptothecin with Dual Shell to Precisely Treat Colorectal Cancer. Nanomedicine. 14(8). 1011–1032. 14 indexed citations

Zhao, Yipu, Ying Cheng, Han Cui, et al.. (2018). Bone metastasis target redox-responsive micell for the treatment of lung cancer bone metastasis and anti-bone resorption. Artificial Cells Nanomedicine and Biotechnology. 46(sup1). 380–391. 11 indexed citations

Liu, Daozhou, Ying Cheng, Han Cui, et al.. (2018). The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle. Nanomedicine Nanotechnology Biology and Medicine. 14(3). 991–1003. 55 indexed citations

Liu, Daozhou, Ying Cheng, Zenghui Teng, et al.. (2018). Charge Reversible and Mitochondria/Nucleus Dual Target Lipid Hybrid Nanoparticles To Enhance Antitumor Activity of Doxorubicin. Molecular Pharmaceutics. 15(3). 1296–1308. 19 indexed citations

10.

Zhao, Yipu, Weiliang Ye, Daozhou Liu, et al.. (2017). Redox and pH dual sensitive bone targeting nanoparticles to treat breast cancer bone metastases and inhibit bone resorption. Nanoscale. 9(19). 6264–6277. 44 indexed citations

11.

Cui, Han, Meng‐Lei Huan, Weiliang Ye, et al.. (2017). Mitochondria and Nucleus Dual Delivery System To Overcome DOX Resistance. Molecular Pharmaceutics. 14(3). 746–756. 38 indexed citations

12.

Cui, Han, Ying Cheng, Miao Liu, et al.. (2017). Charge reversible calcium phosphate lipid hybrid nanoparticle for siRNA delivery. Oncotarget. 8(26). 42772–42788. 17 indexed citations

13.

Zhao, Yuan, Meng‐Lei Huan, Miao Liu, et al.. (2016). Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. Scientific Reports. 6(1). 35267–35267. 96 indexed citations

14.

Du, Jiangbo, Weiliang Ye, Ying Cheng, et al.. (2014). PEG-detachable lipid–polymer hybrid nanoparticle for delivery of chemotherapy drugs to cancer cells. Anti-Cancer Drugs. 25(7). 751–766. 10 indexed citations

15.

Liang, Chunhui, Ren Na, Ying Cheng, et al.. (2014). Synthesis of Doxorubicin α-Linolenic Acid Conjugate and Evaluation of Its Antitumor Activity. Molecular Pharmaceutics. 11(5). 1378–1390. 39 indexed citations

16.

Su, Dan, Ying Cheng, Miao Liu, et al.. (2013). Comparision of Piceid and Resveratrol in Antioxidation and Antiproliferation Activities In Vitro. PLoS ONE. 8(1). e54505–e54505. 130 indexed citations

17.

Huan, Meng‐Lei, Shuang Tian, Han Cui, et al.. (2013). Deposition of Doxorubicin in Rats following Administration of Three Newly Synthesized Doxorubicin Conjugates. BioMed Research International. 2013. 1–8. 5 indexed citations

18.

Huan, Meng‐Lei, Bang‐Le Zhang, Zenghui Teng, et al.. (2012). In Vitro and In Vivo Antitumor Activity of a Novel pH-Activated Polymeric Drug Delivery System for Doxorubicin. PLoS ONE. 7(9). e44116–e44116. 23 indexed citations

19.

Teng, Zenghui, Han Cui, Miao Liu, et al.. (2012). Synthesis of a New pH-Sensitive Folate–Doxorubicin Conjugate and its Antitumor Activity In Vitro. Journal of Pharmaceutical Sciences. 102(2). 530–540. 15 indexed citations

20.

Huan, Meng‐Lei, Han Cui, Zenghui Teng, et al.. (2012). In VivoAnti-Tumor Activity of a New Doxorubicin Conjugateviaα-Linolenic Acid. Bioscience Biotechnology and Biochemistry. 76(8). 1577–1579. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact